Tubulointerstitial nephritis associated with treatment with selective Cox-2 inhibitors, Celecoxib and Rofecoxib

Otros usuarios también vieron estos artículos

mTOR inhibitors in a patient with lupus nephritis; why not? Raquel Berzal, Beatriz Agredano, Marco Gil, María Galindo, Enrique Morales

10.1016/j.nefro.2022.03.005

C3 glomerulonephritis accompanied with lupus nephritis Kubra Kaynar, Beyhan Güvercin, Sahile Safarlı, Sevdegül Mungan, Mustafa Şahin

10.1016/j.nefro.2020.09.006

Basophil activation test in interstitial nephritis. Some comments Salvatore Chirumbolo, Geir Bjørklund, Antonio Vella

10.1016/j.nefro.2019.06.005